|
1
|
Chen Y, Li D, Xu Y, Zhang Y, Tao L, Li S,
Jiang Y and Shen X: Essential oils from Fructus A. zerumbet protect
human aortic endothelial cells from apoptosis induced by Ox-LDL in
vitro. Evid Based Complement Alternat Med. 2014:9568242014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Zhang Y, Zhu Y and Zhang P:
Lipolytic inhibitor G0/G1 switch gene 2 inhibits reactive oxygen
species production and apoptosis in endothelial cells. Am J Physiol
Cell Physiol. 308:C496–C504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang HC, Chen TG, Tai YT, Chen TL, Chiu
WT and Chen RM: Resveratrol attenuates oxidized LDL-evoked Lox-1
signaling and consequently protects against apoptotic insults to
cerebrovascular endothelial cells. J Cereb Blood Flow Metab.
31:842–854. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitra S, Deshmukh A, Sachdeva R, Lu J and
Mehta JL: Oxidized low-density lipoprotein and atherosclerosis
implications in antioxidant therapy. Am J Med Sci. 342:135–142.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross R: The pathogenesis of
atherosclerosis: A perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taye A and El-Sheikh AA: Lectin-like
oxidized low-density lipoprotein receptor 1 pathways. Eur J Clin
Invest. 43:740–745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu S, Ogura S, Chen J, Little PJ, Moss J
and Liu P: LOX-1 in atherosclerosis: Biological functions and
pharmacological modifiers. Cell Mol Life Sci. 70:2859–2872. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pirillo A, Norata GD and Catapano AL:
LOX-1, OxLDL, and atherosclerosis angela. Mediators Inflamm.
2013:1527862013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu W, Alvarez-Dominguez JR and Lodish HF:
Regulation of mammalian cell differentiation by long non-coding
RNAs. EMBO Rep. 13:971–983. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song X, Shan D, Chen J and Jing Q: miRNAs
and lncRNAs in vascular injury and remodeling. Sci China Life Sci.
57:826–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang N, Fu Y, Zhang H, Sima H, Zhu N and
Yang G: LincRNA-p21 activates endoplasmic reticulum stress and
inhibits hepatocellular carcinoma. Oncotarget. 6:28151–28163. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He C, Ding JW, Li S, Wu H, Jiang YR, Yang
W, Teng L and Yang J and Yang J: The role of long intergenic
noncoding RNA p21 in vascular endothelial cells. DNA Cell Biol.
34:677–683. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mackness MI and Durrington PN: Lipoprotein
separation and analysis for clinical studiesLipoprotein Analysis: A
Practical Approach. Converse CA and Skinner ER: Oxford University
Press; Oxford: pp. 1–42. 1992
|
|
17
|
Sparrow CP, Parthasarathy S and Steinberg
D: Enzymatic modification of low density lipoprotein by purified
lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative
modification. J Lipid Res. 29:745–753. 1988.PubMed/NCBI
|
|
18
|
Perissi V, Scafoglio C, Zhang J, Ohgi KA,
Rose DW, Glass CK and Rosenfeld MG: TBL1 and TBLR1 phosphorylation
on regulated gene promoters overcomes dual CtBP and NCoR/SMRT
transcriptional repression checkpoints. Mol Cell. 29:755–766. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmitten TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Pabla N, Wei Q, Dong G, Messing RO,
Wang CY and Dong Z: PKC-delta promotes renal tubular cell apoptosis
associated with proteinuria. J Am Soc Nephrol. 21:1115–1124. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Konishi H, Tanaka M, Takemura Y, Matsuzaki
H, Ono Y, Kikkawa U and Nishizuka Y: Activation of protein kinase C
by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci
USA. 94:pp. 11233–11237. 1997; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramnath RD, Sun J, Adhikari S, Zhi L and
Bhatia M: Role of PKC-delta on substance P-induced chemokine
synthesis in pancreatic acinar cells. Am J Physiol Cell Physiol.
294:C683–C692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin B, Cao Y, Yang H, Xiao B and Lu Z:
MicroRNA-221/222 regulate ox-LDL-induced endothelial apoptosis via
Ets-1/p21 inhibition. Mol Cell Biochem. 405:115–124. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coutinho I, Pereira C, Pereira G,
Gonçalves J, Côrte-Real M and Saraiva L: Distinct regulation of
p53-mediated apoptosis by protein kinase Cα, δ, ε and ζ: Evidence
in yeast for transcription-dependent and -independent p53 apoptotic
mechanisms. Exp Cell Res. 317:1147–1158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu HM, Schally AV, Cheng JC, Zarandi M,
Varga J and Leung PC: Growth hormone-releasing hormone antagonist
induces apoptosis of human endometrial cancer cells through
pkcδ-mediated activation of p53/p21. Cancer Lett. 298:16–25. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schisano B, Tripathi G, McGee K, McTernan
PG and Ceriello A: Glucose oscillations, more than constant high
glucose, induce p53 activation and a metabolic memory in human
endothelial cells. Diabetologia. 54:1219–1226. 2011. View Article : Google Scholar : PubMed/NCBI
|
